Clinical Trial Update: Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating treatment for relapsed or primary refractory aggressive B-cell non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: University of Magdeburg | Conditions: Lymphoma, High-Grade | Phase 2 | Status: UNKNOWN